A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021)

Study Overview
=================
Brief Summary
-----------------
This study will gather information on allergic rhinoconjunctivitis from surveys completed by adults and children.

Official Title
-----------------
National Allergies, Immunotherapy and RhinoConjunctivitis Survey in America

Conditions
-----------------
Allergic Rhinoconjunctivitis

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Diagnosed with hay fever, rhinitis or nasal and/or eye allergies and display symptoms of sneezing, itching, watery eyes, nasal congestion, or other nasal or eye allergy symptoms over the past 12 months OR take any medication for their hay fever, rhinitis, nasal or eye allergies 5 years of age or older Have a telephone Exclusion Criteria: If less than 18 years old and there is no adult available that is knowledgeable about the participant's health

Ages Eligible for Study
-----------------
Minimum Age: 5 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Adults and Children with Allergic Rhinoconjunctivitis (ARC)<br>Adults and children with ARC who complete the survey | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Percentage of Participants Who Experienced Daily Symptoms Due to Allergic Rhinoconjunctivitis (ARC) | Participants were asked about the frequency and severity of ARC symptoms when allergies were at their worst. The percentages of participants who experienced different symptoms of ARC on a daily basis when allergies were at their worst were calculated. | Within 12 months prior to survey | 
| Percentage of Participants Who Experienced Work or School Absence Due to ARC in the Past 12 Months | Participants were asked about the impact of ARC on loss of work and school time. The percentage of participants who experienced work or school absence due to ARC in the prior 12 months was calculated. | Within 12 months prior to survey | 
| Percentage of Participants Who Used Medication to Treat ARC in the Past 12 Months | Participants were asked about prescription and over-the-counter medication use for ARC. The percentages of participants who used prescription and/or over-the-counter medication to treat ARC in the past 12 months were calculated. | Within 12 months prior to survey | 
| Percentage of Participants Who Received Immunotherapy to Treat ARC | Participants who had ever received immunotherapy for ARC were asked about the type of immunotherapy - subcutaneous or sublingual - received. The percentage of participants who received immunotherapy to treat ARC was calculated. | Within 12 months prior to survey | 
| Percentage of Participants Who Received Allergy Shots and Required Supplemental Prescription Allergy Medication | Participants who received subcutaneous immunotherapy (allergy shots) were asked about prescription and over-the-counter medication use. The percentage of participants who received allergy shots to treat ARC, had not taken over-the-counter allergy medication and required supplemental prescription allergy medication for ARC was calculated. | Within 12 months prior to survey | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Percentage of Participants Who Received Allergy Shots and Had a Co-morbid Condition of Asthma | Participants were asked about co-morbid health conditions. The percentage of participants who had received allergy shots to treat ARC and had asthma was calculated. | Within 12 months prior to survey | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Allergies, Immunotherapy